Clinical Trial: A prospective, single-center, exploratory clinical study of sotrocumab in combination with zanubrutinib for patients with chronic lymphocytic leukemia (CLL) who have received zanubrutinib monotherapy for >= 1 year (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-center, exploratory clinical study of sotrocumab in combination with zanubrutinib for patients with chronic lymphocytic leukemia (CLL) who have received zanubrutinib monotherapy for >= 1 year'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133570

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337673

Published by HT Digital Content Services with permission from Health Dai...